FDA Approved: RISEDRONATE SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's risendronate sodium generic from an Original Application (ANDA 077132), enabling marketing of a risendronate sodium tablet product. The appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

ORIG AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)